Science Applications International Corporation · NASDAQ:SAIC

Science Applications International — Q2 2026 Earnings Presentation

16 slides from Science Applications International's earnings presentation, Sep 4, 2025

  1. Slide 1: Financial Results FY26 2Q Supplemental Financial Presentation

    FINANCIAL RESULTS FY26 2Q SUPPLEMENTAL FINANCIAL PRESENTATION SEPTEMBER 4, 2025 SAIC PROPRIETARY INFORMATION I © SAIC. ALL RIGHTS RESERVED

  2. Slide 2: Forward Looking Statements

    FORWARD LOOKING STATEMENTS Certain statements in this presentation are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Words such as “may,” “will,” “should,” “expects,” “intends,” “projects,” “plans,” “believes,” “estimates,” “targets,” “antic

  3. Slide 3: Key Highlights

    KEY HIGHLIGHTS Lowering revenue outlook for FY26 and FY27 largely due to a more challenging NAVIGATING NEAR-TERM REVENUE environment for on-contract growth and new business award delays with more PRESSURE limited impact from program cancellations DRIVING EFFICIENCY WHILE Implementing cost efficiency

  4. Slide 4: Business Development Progress Continues

    BUSINESS DEVELOPMENT PROGRESS CONTINUES TCV of Submitted Bids* >$30 2.5x $30 $28 $28 to $30 2.0x $25 $24 $22 1.5x TARGET $ in bil. Strategic $20 Civilian 1.0x $17 0.5x $15 Enterprise / 0.0x Mission IT F2Q20 F3Q20 F4Q20 F1Q21 F2Q21 F3Q21 F4Q21 F1Q22 F2Q22 F3Q22 F4Q22 F1Q23 F2Q23 F3Q23 F4Q23 F1Q24 F2Q

  5. Slide 5: FY26 2Q Results

    FY26 2Q RESULTS(1) ADJUSTED REVENUE ADJUSTED EBITDA (2) FREE CASH FLOW (2) DILUTED EPS (2) $1,818 $185 $3.63 $1,769 $170 $241 (3%) 10.5% 9.4% $2.05 $150 FY25 FY26 FY25 FY26 FY25 FY26 FY25 FY26 Army PRISM Higher Program Performance Lower Share Count Unfavorable W/C Air Force NITES Favorable Legal Set

  6. Slide 6: Fiscal Year 2026 Guidance

    FISCAL YEAR 2026 GUIDANCE CURRENT FISCAL YEAR 2026 PRIOR FISCAL YEAR 2026 GUIDANCE GUIDANCE Revenue $7.250B - $7.325B $7.60B - $7.75B Organic Growth Approximately (2% – 3%) 2% - 4% Adjusted EBITDA(1) $680M - $690M $715M - $735M Adjusted EBITDA %(1) 9.3% - 9.5% 9.4% - 9.6% Adjusted Diluted EPS (1) $9

  7. Slide 7: Updated Fiscal Year 2026 Guidance Walk

    UPDATED FISCAL YEAR 2026 GUIDANCE WALK $7,800 $740 $7,700 $7,675 $725 ADJ. EBITDA $720 $7,600 REVENUE ($100) $700 $7,500 ($30) $685 $7,400 $680 ($10) $7,300 $7,285 ($290) $660 $7,200 $640 $7,100 $620 $7,000 PROGRAM CANCELLATIONS / CURRENT FY26 GUIDANCE $600 DEFUNDING PRIOR FY26 AWARD DELAYS INCL. ON

  8. Slide 8: Multi-Year Financial Targets

    MULTI-YEAR FINANCIAL TARGETS FY24 FY25 FY26 FY27 $7.444B Revenue ($7.26B excl. L&SCM) $7.479B $7.250B - $7.325B $7.30B - $7.50B Organic Growth 7.4% 3.1% (2% - 3%) 0% - 3% Adjusted EBITDA %* 9.0% 9.5% 9.3% – 9.5% 9.5% - 9.7% Adjusted EBITDA $668M $710M $680M - $690M $705M - $715M Adjusted Diluted EPS

  9. Slide 9: SAIC Historical Share Repurchase Programs

    SAIC HISTORICAL SHARE REPURCHASE PROGRAMS REPURCHASE AVG. ANNUALIZED INCREMENTAL APPROXIMATE AVG. SHARES AVG. PRICE OF AUTHORIZATION TOTAL “CURRENT” AUTHORIZATION FCF** / SHARE SHARES ADDED TO MONTHS TO REPURCHASED PER REPURCHASED DATE AUTHORIZATION AS % OF DILUTED DURING AUTHORIZATION COMPLETE MONT

  10. Slide 10: SAIC Historical Backlog and Book-to-Bill

    SAIC HISTORICAL BACKLOG AND BOOK-TO-BILL Backlog TTM Book-to-Bill $25 2.5x Total Backlog ($ in billions) $20 2.0x $15 1.5x $10 1.0x $5 0.5x $0 0.0x F1Q19 F2Q19 F3Q19 F4Q19 F1Q20 F2Q20 F3Q20 F4Q20 F1Q21 F2Q21 F3Q21 F4Q21 F1Q22 F2Q22 F3Q22 F4Q22 F1Q23 F2Q23 F3Q23 F4Q23 F1Q24 F2Q24 F3Q24 F4Q24 F1Q25 F2

  11. Slide 11: Appendix

    APPENDIX SAIC PROPRIETARY INFORMATION I © SAIC. ALL RIGHTS RESERVED 11

  12. Slide 12: Non-GAAP Reconciliation – Adjusted Operating Income

    NON-GAAP RECONCILIATION – ADJUSTED OPERATING INCOME Adjusted operating income is a performance measure that primarily excludes the impact of non-recurring transactions and activities that we do not consider to be indicative of our ongoing operating performance. Adjusted operating income is calculate

  13. Slide 13: Non-GAAP Reconciliation – EBITDA and Adjusted EBITDA

    NON-GAAP RECONCILIATION – EBITDA AND ADJUSTED EBITDA EBITDA is a performance measure that is calculated by taking net income and excluding interest and loss on sale of receivables, provision for income taxes, and depreciation and amortization. Adjusted EBITDA is a performance measure that excludes t

  14. Slide 14: Non-GAAP Reconciliation – Adjusted Diluted Earnings Per Share

    NON-GAAP RECONCILIATION – ADJUSTED DILUTED EARNINGS PER SHARE Adjusted diluted earnings per share is a performance measure that excludes the impact of non-recurring transactions that we do not consider to be indicative of our ongoing operating performance. The acquisition and integration costs relat

  15. Slide 15: Non-GAAP Reconciliation – Adjusted Diluted Earnings Per Share

    NON-GAAP RECONCILIATION – ADJUSTED DILUTED EARNINGS PER SHARE Adjusted diluted earnings per share is a performance measure that excludes the impact of non-recurring transactions that we do not consider to be indicative of our ongoing operating performance. The acquisition and integration costs relat

  16. Slide 16: Non-GAAP Reconciliation – Free Cash Flow

    NON-GAAP RECONCILIATION – FREE CASH FLOW Free cash flow is calculated by taking cash flows provided by operating activities less expenditures for property, plant, and equipment and less cash flows from our Master Accounts Receivable Purchasing Agreement (MARPA Facility) for the sale of certain desig

Science Applications International — Q2 2026 Earnings Presentation on 6ix